173 related articles for article (PubMed ID: 9557928)
41. Effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist, and an endothelin receptor antagonist on renal afferent arteriolar structure.
Skov K; Fenger-Grøn J; Mulvany MJ
Hypertension; 1996 Sep; 28(3):464-71. PubMed ID: 8794834
[TBL] [Abstract][Full Text] [Related]
42. Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertension.
Oparil S
Am J Hypertens; 1998 Apr; 11(4 Pt 3):88S-94S. PubMed ID: 9607372
[TBL] [Abstract][Full Text] [Related]
43. Cardioprotective effects of an angiotensin-converting-enzyme inhibitor, imidapril, and Ca2+ channel antagonist, amlodipine, in spontaneously hypertensive rats at established stage of hypertension.
Yokota S; Naito Y; Yoshida H; Ohara N; Adachi T; Narita H
Jpn J Pharmacol; 1998 May; 77(1):79-87. PubMed ID: 9639063
[TBL] [Abstract][Full Text] [Related]
44. Influence of graded changes in vasomotor tone on the carotid arterial mechanics in live spontaneously hypertensive rats.
Lacolley P; Ghodsi N; Glazer E; Challande P; Brissac AM; Safar ME; Laurent S
Br J Pharmacol; 1995 Aug; 115(7):1235-44. PubMed ID: 7582551
[TBL] [Abstract][Full Text] [Related]
45. [Edema-inducing properties of lacidipine, nitrendipine and nifedipine in the spontaneously hypertensive rat].
Rota R; Pallotta M; Garay R; Giraud F; Courseau C; Hannaert P
Arch Mal Coeur Vaiss; 1994 Aug; 87(8):975-7. PubMed ID: 7755475
[TBL] [Abstract][Full Text] [Related]
46. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
Hefti F; Clozel JP; Osterrieder W
Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
[TBL] [Abstract][Full Text] [Related]
47. Vascular versus myocardial selectivity of dihydropyridine calcium antagonists as studied in vivo and in vitro.
Nordlander M; Abrahamsson T; Akerblom B; Thalén P
Pharmacol Toxicol; 1995 Jan; 76(1):56-62. PubMed ID: 7753759
[TBL] [Abstract][Full Text] [Related]
48. A study of the renal actions of amlodipine in the normotensive and spontaneously hypertensive rat.
Johns EJ
Br J Pharmacol; 1988 Jun; 94(2):311-8. PubMed ID: 2969266
[TBL] [Abstract][Full Text] [Related]
49. Unique cardioprotective action of the new calcium antagonist mibefradil.
Schulz R; Post H; Jalowy A; Backenköhler U; Dörge H; Vahlhaus C; Heusch G
Circulation; 1999 Jan; 99(2):305-11. PubMed ID: 9892599
[TBL] [Abstract][Full Text] [Related]
50. Preferential renal and mesenteric vasodilation induced by barnidipine and amlodipine in spontaneously hypertensive rats.
Janssen BJ; Kam KL; Smits JF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):414-21. PubMed ID: 11692224
[TBL] [Abstract][Full Text] [Related]
51. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.
Cremers B; Flesch M; Südkamp M; Böhm M
J Cardiovasc Pharmacol; 1997 May; 29(5):692-6. PubMed ID: 9213214
[TBL] [Abstract][Full Text] [Related]
52. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
[TBL] [Abstract][Full Text] [Related]
53. Cytosolic calcium and lymphoproliferative response during calcium antagonism in men.
Lijnen P; Fagard R; Petrov V
Eur J Clin Pharmacol; 1999 Feb; 54(12):911-5. PubMed ID: 10192750
[TBL] [Abstract][Full Text] [Related]
54. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.
Schmitt R; Clozel JP; Iberg N; Bühler FR
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1161-5. PubMed ID: 7627710
[TBL] [Abstract][Full Text] [Related]
55. Amlodipine therapy corrects renal abnormalities encountered in the hypertensive state.
Reams GP; Lau A; Hamory A; Bauer JH
Am J Kidney Dis; 1987 Dec; 10(6):446-51. PubMed ID: 2961256
[TBL] [Abstract][Full Text] [Related]
56. Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
Lapointe N; Chen H; Qi S; Xu D; Daloze P; Dumont L
Eur Surg Res; 1999; 31(3):259-66. PubMed ID: 10352354
[TBL] [Abstract][Full Text] [Related]
57. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
Am J Cardiol; 1989 Nov; 64(17):21I-34I. PubMed ID: 2530884
[TBL] [Abstract][Full Text] [Related]
58. Effect of different dihydropyridine-type Ca2+ antagonists on left ventricle hypertrophy and coronary changes in spontaneously hypertensive rats.
Tomassoni D; Sabbatini M; Amenta F
J Cardiovasc Pharmacol; 2003 Apr; 41(4):544-52. PubMed ID: 12658055
[TBL] [Abstract][Full Text] [Related]
59. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
Min JY; Sandmann S; Meissner A; Unger T; Simon R
J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
[TBL] [Abstract][Full Text] [Related]
60. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
Xia QG; Reinecke A; Dorenkamp M; Storz C; Bitterling H; Penz S; Cleutjens J; Daemen MJ; Simon R; Unger T
Acta Pharmacol Sin; 2004 Jun; 25(6):763-8. PubMed ID: 15169629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
